EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 210 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2016. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $87,465,000 | +21.1% | 2,663,371 | +16.3% | 0.02% | +6.7% |
Q3 2016 | $72,216,000 | +28.1% | 2,290,379 | +14.2% | 0.02% | +25.0% |
Q2 2016 | $56,387,000 | -17.9% | 2,005,227 | +6.1% | 0.01% | -25.0% |
Q1 2016 | $68,720,000 | -9.7% | 1,890,512 | -0.6% | 0.02% | -11.1% |
Q4 2015 | $76,121,000 | +48.9% | 1,902,555 | +6.0% | 0.02% | +38.5% |
Q3 2015 | $51,137,000 | -10.4% | 1,794,922 | +3.6% | 0.01% | -7.1% |
Q2 2015 | $57,069,000 | +16.7% | 1,731,979 | +1.9% | 0.01% | +16.7% |
Q1 2015 | $48,887,000 | +12.2% | 1,699,814 | +6.2% | 0.01% | +9.1% |
Q4 2014 | $43,589,000 | +40.9% | 1,600,758 | +10.3% | 0.01% | +22.2% |
Q3 2014 | $30,927,000 | -8.2% | 1,451,302 | -3.2% | 0.01% | 0.0% |
Q2 2014 | $33,681,000 | -13.2% | 1,499,600 | -2.4% | 0.01% | -25.0% |
Q1 2014 | $38,807,000 | +9.9% | 1,535,713 | -0.0% | 0.01% | +9.1% |
Q4 2013 | $35,309,000 | +24.4% | 1,535,843 | +3.0% | 0.01% | +10.0% |
Q3 2013 | $28,392,000 | +51.7% | 1,490,413 | +14.8% | 0.01% | +42.9% |
Q2 2013 | $18,722,000 | – | 1,298,360 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |